Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

BACKGROUND: Compared with older 5‐HT(3) receptor antagonists, palonosetron requires fewer drug administrations to prevent chemotherapy‐induced nausea and vomiting (CINV) following multiple‐day chemotherapy. We conducted a phase II multicenter study comparing palonosetron plus aprepitant to palonoset...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Renzo, Nicola, Melillo, Lorella, Porretto, Fernando, Dargenio, Michela, Pavone, Vincenzo, Pastore, Domenico, Mazza, Patrizio, Mannina, Donato, Merenda, Anxur, Cascavilla, Nicola, Greco, Giuseppina, Matera, Rosella, Bonizzoni, Erminio, Celio, Luigi, Musso, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943081/
https://www.ncbi.nlm.nih.gov/pubmed/31725196
http://dx.doi.org/10.1002/cam4.2628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943081/
https://www.ncbi.nlm.nih.gov/pubmed/31725196
http://dx.doi.org/10.1002/cam4.2628

Ejemplares similares